켐베이스

비상장계속사업자

chembase co.,ltd

백종구

Investment Review Report

Auto-filled from disclosures & public data + AI-drafted analysis. Edit, then export to PDF/DOCX.

Editor

1.Deal Terms

2.Valuation / Exit Assumptions

Exit Scenarios100M KRW

3.Fund Eligibility

Fund mandate eligibility — no data, enter manually

Enter fund mandate requirements and applicability (Y/N) to include a table in the report.

4.Capital Changes

Not in DART — enter capital-raise history manually

Enter capital changes such as founding capital and paid-in increases.

5.Stock Options

Enter manually

Enter stock option grant history.

6.Investment Highlights

AI draft — editable

Click 'Generate AI draft' to populate data-grounded investment highlights.

7.Investment Risks

AI draft — editable

Risks are populated after 'Generate AI draft'.

8.Market Analysis

AI draft — editable

9.Business Analysis

AI draft — editable

10.Conclusion (Investment Opinion)

AI draft — editable

11.P&L Projection

Analyst estimates, manual entry (100M KRW). Generates a trend chart & table.

Enter projected revenue / op. profit / net income (100M KRW) by year to add a trend chart and table.
Preview— the document below is saved as PDF/DOCX

Investment Review Report

켐베이스

Business Reg. No. 3088128838 · CEO 백종구

I.Investment Overview

Target켐베이스 (3088128838)
Investment
Post-deal stake
ValuationPre — / Post —

II.Investment Highlights

No investment highlights written yet.

III.Investment Risks

No risks written yet.

IV.Company Profile

회사명켐베이스
영문명chembase co.,ltd
대표자백종구
사업자등록번호3088128838
법인등록번호1613110025922
설립일2008.09.01
종업원수24명

V.Workforce

24

Current headcount · 2026.06 as of

VI.Financial Summary

Per DART disclosure · in 억/만원 (KRW)

Financial trend (100M KRW)

매출액100M KRW122.52021125.420221602023114.52024126.52025
영업이익100M KRW220215.820221.320231.520240.12025
순이익100M KRW3.720219.82022-0.620230.720243.22025
Item20252024202320222021
자산총계204.2억원190.3억원172.3억원167.3억원131.5억원
부채총계146.6억원134.9억원117.1억원109억원79억원
자본총계57.6억원55.4억원55.2억원58.3억원52.5억원
매출액126.5억원114.5억원160억원125.4억원122.5억원
영업이익1,428만원1.5억원1.3억원5.8억원2억원
순이익3.2억원7,244만원-6,047만원9.8억원3.7억원

VII.Financial Ratios

FY2025 basis

0.11%

영업이익률

2.54%

순이익률

1.58%

ROA

5.59%

ROE

254.54%

부채비율

28.21%

자기자본비율

VIII.R&D Activity

Fields 생명과학 > 산업바이오 · 화학 > 고분자화학

Keywords 바이오매스, 엔진 커버, 유리섬유강화플라스틱, 탄소섬유, 전이온도

YearProjectsPapersPatents
2026100
2025100
2024110
2023000
2022101
2021100
2019001
2018001
2017002
2016200
2015101
2012001
2011200
2010200

IX.Valuation & Exit Plan

Exit valuation
Holding period5y
Enter exit assumptions (investment, stake, exit valuation, period) to see MOIC·IRR.

This report compiles disclosure & public data and AI-drafts some sections as a research aid. It is not investment advice; the user bears final responsibility for facts and investment decisions.

켐베이스 투심보고서 | Alpha Lenz